日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Clozapine Therapy With or Without Antipsychotic Augmentation: A Retrospective Evaluation of Prescribing Practices in a Canadian Provincial Residential Treatment Centre for Concurrent Disorders: Traitement par la clozapine avec ou sans intensification à l'aide d'antipsychotiques : évaluation rétrospective des pratiques de prescription dans un centre de traitement résidentiel provincial canadien pour les troubles concomitants

有或没有抗精神病药物强化的氯氮平治疗:对加拿大省级住院治疗中心并发疾病处方实践的回顾性评估:在没有加强抗精神病药物的情况下氯氮平的治疗:加拿大省级住院治疗中心的处方实践评估回顾烦恼伴随物

Frankow, Laura; Bousman, Chad A; Mathew, Nickie; Rafizadeh, Reza

C-Reactive Protein and Neutrophil-To-Lymphocyte Ratio: Can They Be Used Interchangeably in Tracking Clozapine-Related Inflammation?

C反应蛋白和中性粒细胞与淋巴细胞比率:它们能否在追踪氯氮平相关炎症中互换使用?

Bihelek, Nicoline; Bousman, Chad A; Honer, William G; Rafizadeh, Reza

Estimating the Frequency of False-Negative Pharmacogenetic Test Results by Self-Reported Ancestry

根据自我报告的祖先信息估计药物遗传学检测假阴性结果的频率

Siu, Weng-Sam; Maruf, Abdullah Al; Shaheen, Sarker M; McCloud, Ryden; Heintz, Madison; McAusland, Laina; Arnold, Paul D; Bousman, Chad A

Prevalence of Actionable Pharmacogenetic Genotype Frequencies, Cautionary Medication Use, and Polypharmacy in Community-Dwelling Older Adults

社区老年人中可操作的药物遗传基因型频率、谨慎用药和多重用药的患病率

Bousman, Chad A; Narang, Ankita; Al Bkhetan, Ziad; Woods, Robyn L; Orchard, Suzanne G; Owen, Alice J; Fravel, Michelle A; Gilmartin-Thomas, Julia; Ryan, Joanne; Fransquet, Peter D; Wolfe, Rory; Yu, Chenglong; McNeil, John J; Lacaze, Paul; Ernst, Michael E

Prevalence Estimates of Cytochrome P450 Phenoconversion in Youth Receiving Pharmacotherapy for Mental Health Conditions

接受精神健康药物治疗的青少年中细胞色素 P450 表型转化患病率估计

Gerlach, Samuel; Maruf, Abdullah Al; Shaheen, Sarker M; McCloud, Ryden; Heintz, Madison; McAusland, Laina; Arnold, Paul D; Bousman, Chad A

Impact of patient-specific factors on clozapine metabolism in individuals with treatment-resistant schizophrenia or schizoaffective disorder

患者特异性因素对难治性精神分裂症或分裂情感性障碍患者氯氮平代谢的影响

Rafizadeh, Reza; Sooch, Anmol; Risi, Alessia; Bihelek, Nicoline; Kanegawa, Kyler; Barr, Alasdair M; White, Randall F; Schütz, Christian G; Bousman, Chad A

Virtual twins for model-informed precision dosing of clozapine in patients with treatment-resistant schizophrenia

利用虚拟孪生模型对难治性精神分裂症患者进行氯氮平精准给药

Mostafa, Sam; Rafizadeh, Reza; Polasek, Thomas M; Bousman, Chad A; Rostami-Hodjegan, Amin; Stowe, Robert; Carrion, Prescilla; Sheffield, Leslie J; Kirkpatrick, Carl M J

Recommendations for pharmacogenetic testing in clinical practice guidelines in the US

美国临床实践指南中关于药物基因组学检测的建议

Hertz, Daniel L; Bousman, Chad A; McLeod, Howard L; Monte, Andrew A; Voora, Deepak; Orlando, Lori A; Crutchley, Rustin D; Brown, Benjamin; Teeple, Wrenda; Rogers, Sara; Patel, Jai N

Association of clozapine treatment and rate of methamphetamine or amphetamine relapses and abstinence among individuals with concurrent schizophrenia spectrum and amphetamine use disorder: A retrospective cohort study

氯氮平治疗与合并精神分裂症谱系障碍和苯丙胺使用障碍患者的甲基苯丙胺或苯丙胺复发率及戒断率之间的关联:一项回顾性队列研究

Rafizadeh, Reza; Frankow, Laura; Mahmood, Hajer; Poonia, Sukhpreet; Mathew, Nickie; Danilewitz, Marlon; Bousman, Chad A; Honer, William G; Schütz, Christian G

Effects of clozapine treatment on the improvement of substance use disorders other than nicotine in individuals with schizophrenia spectrum disorders: A systematic review and meta-analysis

氯氮平治疗对精神分裂症谱系障碍患者除尼古丁以外的物质使用障碍改善效果:系统评价和荟萃分析

Rafizadeh, Reza; Danilewitz, Marlon; Bousman, Chad A; Mathew, Nickie; White, Randall F; Bahji, Anees; Honer, William G; Schütz, Christian G